GPT and hepatocellular carcinoma: The risk of HCC in patients with ALT elevation observed in our study (1.82–2.75-fold) is kind of lower than the 5.8–6.8-fold increases reported in large CHB cohort studies from Taiwan and Hong Kong (7, 8).